MedTrace Logo

Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin

NCT05694221 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-08-05

No results posted yet for this study

Summary

This is a study of a drug drug interaction between Supaglutide and Digoxin or Metformin.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Supaglutide injection

Administered subcutaneously in the Supaglutide arms

DRUG

Digoxin

Oral Administration

DRUG

Metformin

Oral Administration

Sponsors & Collaborators

  • Huashan Hospital

    collaborator OTHER

  • Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

    lead OTHER

Principal Investigators

  • Jing Zhang · Huashan Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-20
Primary Completion
2023-06-06
Completion
2023-08-17

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05694221 on ClinicalTrials.gov